Malaria vaccine deployment in Africa: focus on Ghana

Simple item page
dc.contributor.authorKoram, K.A.
dc.contributor.authorAsante, K.P.
dc.contributor.authorBinka, F.N.
dc.date.accessioned2019-10-01T11:03:17Z
dc.date.available2019-10-01T11:03:17Z
dc.date.issued2019-06-02
dc.descriptionResearch Articleen_US
dc.description.abstractThe announcement by the Ghana Health Service /Ministry of Health at the beginning of May to begin the pilot implementation of the malaria vaccine – RTS,S/AS01 (Mosquirix®) – manufactured by GSK Biologicals was greeted with rumours about conspiracy theories of secret agenda to depopulate Africa through the use of vaccines and all the other stories that are often propagated by the anti vaxxers. This was not unlike the fear and panic spread throughout the country that prevented investigators from conducting clinical trials on new vaccines against the Ebola virus disease a few years ago.en_US
dc.identifier.otherhttp://dx.doi.org/10.4314/gmj.v53i2.2
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/32371
dc.language.isoenen_US
dc.publisherGhana medical journalen_US
dc.relation.ispartofseries53;2
dc.subjectMalariaen_US
dc.subjectVaccineen_US
dc.subjectGhanaen_US
dc.subjectDevelopmenten_US
dc.titleMalaria vaccine deployment in Africa: focus on Ghanaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Malaria-vaccine-deployment-in-Africa-focus-on-GhanaGhana-medical-journal.pdf
Size:
128.96 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Epidemiology Department